Medtronic hit with FDA warning letter for diabetes devices


The company received a warning letter on Wednesday related to inadequate quality requirements at the headquarters for its diabetes business. It comes after Medtronic expanded a recall of its MiniMed 600 series insulin pumps.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.